Dancing Protein

Awards & Grants, Computational Health, ICB, Molecular Targets and Therapeutics, STB,

Reid Alderson Receives ERC Starting Grant for Protein-DANCE

Dr. Reid Alderson from the Institute of Structural Biology and the Institute of Computational Biology at Helmholtz Munich has received a Starting Grant from the European Research Council (ERC). Through the Protein-DANCE project, he will develop a new…

Brain with neural Laptop

AI, Awards & Grants, Computational Health, HCA,

Marcel Binz Receives ERC Starting Grant for MIDAS

Dr. Marcel Binz from the Institute for Human-Centered AI at Helmholtz Munich has received a Starting Grant from the European Research Council (ERC). Through the MIDAS project, he will develop large-scale computational models designed to simulate,…

Proteinbausteine mit synthetischen Proteinstrukturen als RNA-Transporter werden mithilfe generativer KI entworfen_Helles Bild

AI, New Research Findings, Stem Cells, IDG, ISF,

AI-Designed Proteins Enable a New Generation of RNA Transporters

Researchers at Helmholtz Munich and the Technical University of Munich (TUM) have developed Synthetic Transfer Vehicles (STVs), an entirely new class of RNA transporters. To do so, they combined naturally occurring protein building blocks with…

Closeup timelapse of layered muscle fibers diminishing over time illustrating severe muscle atrophy in cancer cachexia.

New Research Findings, Diabetes, IDC,

Cancer Cachexia: How a Tumor Protein Drives Wasting in the Body

Researchers at Helmholtz Munich, the Heidelberg Faculty of Medicine at Heidelberg University, the German Center for Diabetes Research (DZD) and the Technical University of Munich (TUM), have identified a previously unknown mechanism that can drive…

Medical diagnostic systems using ai to analyze patient data

IFE,

From pixels to discovery: microscopy image analysis with SpotMAX

What if analysing thousands of microscopic signals could be done in minutes rather than hours? Researchers at Helmholtz Munich have developed SpotMAX, a new AI-powered open-source framework that automates the detection and quantification of…

Public Engagement, Molecular Targets and Therapeutics, MCD,

Marcus Conrad Receives Inaugural Raghav Prize for Rare Disease Research

The CureGPX4 Foundation has named Prof. Marcus Conrad, Director of the Institute of Metabolism and Cell Death at Helmholtz Munich, as the first recipient of the Raghav Prize for Rare Disease and Citizen Science. The prize recognizes his research into…